Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 058750/0521 | |
| Pages: | 3 |
| | Recorded: | 01/14/2022 | | |
| Attorney Dkt #: | 29539-0438US1 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
16612109
|
Filing Dt:
|
11/08/2019
|
|
Publication #:
|
|
Pub Dt:
|
03/26/2020
| | | | |
|
Title:
|
Cancer Treatment with a CXCL12 Signaling Inhibitor and an Immune Checkpoint Inhibitor
|
|
|
Assignee
|
|
|
|
|
| 1735 BUFORD HIGHWAY, STE. 215-113 |
| CUMMING, GEORGIA 30041 |
|
|
Correspondence name and address
|
| |
MATTHEW K. KNABEL
|
| |
FISH & RICHARDSON P.C.
|
| |
P.O.BOX 1022
|
| |
MINNEAPOLIS, MN 55440-1022
|
Search Results as of:
05/02/2024 09:26 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
